Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EGF-like and EMI domain-containing 1, pseudogene (EGFEM1P) is a genetically defined pseudogene located on chromosome 3. Pseudogenes are genomic loci that resemble functional protein-coding genes but are considered non-functional due to mutations that disrupt their coding capacity[1][3][4]. EGFEM1P is predicted but not confirmed to have scavenger receptor activity and a possible role in vesicle-mediated transport, though these annotations are computational and lack experimental validation[1][4]. It does not encode a functional protein and is not currently recognized as a therapeutic target, biomarker, or relevant for drug development. Like other pseudogenes, if transcribed, it could theoretically compete for microRNA binding and thus indirectly regulate its parent gene or related pathways—a mechanism described for other pseudogenes such as PTENP1 in cancer, but not proven for EGFEM1P[5]. Current evidence does not support a clinical or biological function beyond basic genomic annotation.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EGF-like and EMI domain-containing 1, pseudogene (EGFEM1P).